10/6/2026
FDA seeks public input on ibogaine trial design
Request focuses on safety, dosing, and oversight for early-phase trials.
Topic archive
2 stories
10/6/2026
Request focuses on safety, dosing, and oversight for early-phase trials.
10/5/2026
Agency requests feedback on clinical trial design for ibogaine drug products.